annual operating expenses:
$2.10B+$301.70M(+16.76%)Summary
- As of today (August 25, 2025), ALNY annual total operating expenses is $2.10 billion, with the most recent change of +$301.70 million (+16.76%) on December 31, 2024.
- During the last 3 years, ALNY annual operating expenses has risen by +$688.96 million (+48.77%).
- ALNY annual operating expenses is now at all-time high.
Performance
ALNY Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$646.93M+$141.86M(+28.09%)Summary
- As of today (August 25, 2025), ALNY quarterly total operating expenses is $646.93 million, with the most recent change of +$141.86 million (+28.09%) on June 30, 2025.
- Over the past year, ALNY quarterly operating expenses has increased by +$104.40 million (+19.24%).
- ALNY quarterly operating expenses is now at all-time high.
Performance
ALNY quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ALNY Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.8% | +19.2% |
| 3 y3 years | +48.8% | +72.2% |
| 5 y5 years | +85.3% | +128.7% |
ALNY Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.8% | at high | +72.2% |
| 5 y | 5-year | at high | +85.3% | at high | +128.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ALNY Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $646.93M(+28.1%) |
| Mar 2025 | - | $505.07M(-15.2%) |
| Dec 2024 | $2.10B(+16.8%) | $595.51M(+21.1%) |
| Sep 2024 | - | $491.92M(-9.3%) |
| Jun 2024 | - | $542.54M(+15.0%) |
| Mar 2024 | - | $471.79M(+0.3%) |
| Dec 2023 | $1.80B(+8.9%) | $470.26M(+4.0%) |
| Sep 2023 | - | $452.35M(-2.3%) |
| Jun 2023 | - | $463.21M(+11.8%) |
| Mar 2023 | - | $414.23M(-12.3%) |
| Dec 2022 | $1.65B(+17.0%) | $472.38M(-1.8%) |
| Sep 2022 | - | $481.23M(+28.1%) |
| Jun 2022 | - | $375.70M(+15.8%) |
| Mar 2022 | - | $324.36M(-21.9%) |
| Dec 2021 | $1.41B(+13.6%) | $415.43M(+23.4%) |
| Sep 2021 | - | $336.65M(+2.6%) |
| Jun 2021 | - | $327.96M(-1.4%) |
| Mar 2021 | - | $332.76M(-0.6%) |
| Dec 2020 | $1.24B(+9.6%) | $334.76M(+1.7%) |
| Sep 2020 | - | $329.25M(+16.4%) |
| Jun 2020 | - | $282.89M(-4.5%) |
| Mar 2020 | - | $296.33M(-17.1%) |
| Dec 2019 | $1.13B(+27.7%) | $357.58M(+27.2%) |
| Sep 2019 | - | $281.15M(+5.3%) |
| Jun 2019 | - | $266.91M(+29.2%) |
| Mar 2019 | - | $206.53M(-13.8%) |
| Dec 2018 | $887.78M(+50.5%) | $239.72M(-5.3%) |
| Sep 2018 | - | $253.24M(+31.7%) |
| Jun 2018 | - | $192.35M(+30.5%) |
| Mar 2018 | - | $147.41M(-18.8%) |
| Dec 2017 | $590.00M(+25.1%) | $181.51M(+44.3%) |
| Sep 2017 | - | $125.80M(+4.4%) |
| Jun 2017 | - | $120.47M(+13.1%) |
| Mar 2017 | - | $106.51M(-7.7%) |
| Dec 2016 | $471.75M(+39.9%) | $115.43M(+8.2%) |
| Sep 2016 | - | $106.68M(+15.4%) |
| Jun 2016 | - | $92.45M(-16.0%) |
| Mar 2016 | - | $110.03M(+18.9%) |
| Dec 2015 | $337.11M(+43.6%) | $92.51M(+18.1%) |
| Sep 2015 | - | $78.33M(+7.4%) |
| Jun 2015 | - | $72.94M(+39.7%) |
| Mar 2015 | - | $52.22M(+14.2%) |
| Dec 2014 | $234.78M | $45.71M(+1.1%) |
| Sep 2014 | - | $45.20M(-7.6%) |
| Jun 2014 | - | $48.90M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $44.41M(+50.1%) |
| Dec 2013 | $140.11M(+7.5%) | $29.59M(-8.2%) |
| Sep 2013 | - | $32.23M(+51.2%) |
| Jun 2013 | - | $21.31M(+117.4%) |
| Mar 2013 | - | $9.80M(-58.0%) |
| Dec 2012 | $130.29M(-5.3%) | $23.35M(+28.7%) |
| Sep 2012 | - | $18.15M(-40.2%) |
| Jun 2012 | - | $30.35M(+3.4%) |
| Mar 2012 | - | $29.36M(-10.5%) |
| Dec 2011 | $137.57M(-4.3%) | $32.80M(+2.6%) |
| Sep 2011 | - | $31.97M(+143.7%) |
| Jun 2011 | - | $13.12M(-16.3%) |
| Mar 2011 | - | $15.68M(-51.5%) |
| Dec 2010 | $143.78M(-3.3%) | $32.31M(+270.2%) |
| Sep 2010 | - | $8.73M(-24.9%) |
| Jun 2010 | - | $11.63M(+2.8%) |
| Mar 2010 | - | $11.31M(+40.1%) |
| Dec 2009 | $148.64M(+19.9%) | $8.07M(-16.4%) |
| Sep 2009 | - | $9.65M(-56.9%) |
| Jun 2009 | - | $22.41M(+180.9%) |
| Mar 2009 | - | $7.98M(+2.1%) |
| Dec 2008 | $124.00M(-13.9%) | $7.81M(+141.6%) |
| Sep 2008 | - | $3.23M(-74.8%) |
| Jun 2008 | - | $12.83M(+224.3%) |
| Mar 2008 | - | $3.96M(+36.8%) |
| Dec 2007 | $144.07M(+116.9%) | $2.89M(-93.9%) |
| Sep 2007 | - | $47.54M(+217.9%) |
| Jun 2007 | - | $14.95M(-37.7%) |
| Mar 2007 | - | $23.99M(+140.2%) |
| Dec 2006 | $66.43M(+35.1%) | $9.99M(+16.1%) |
| Sep 2006 | - | $8.60M(-22.5%) |
| Jun 2006 | - | $11.11M(+13.4%) |
| Mar 2006 | - | $9.80M(-34.3%) |
| Dec 2005 | $49.19M(+34.6%) | $14.92M(+39.8%) |
| Sep 2005 | - | $10.67M(-4.8%) |
| Jun 2005 | - | $11.20M(+67.7%) |
| Mar 2005 | - | $6.68M(+20.8%) |
| Dec 2004 | $36.54M(+77.2%) | $5.53M(-13.9%) |
| Sep 2004 | - | $6.43M(-7.9%) |
| Jun 2004 | - | $6.97M(-47.7%) |
| Mar 2004 | - | $13.33M(+647.3%) |
| Dec 2003 | $20.62M(+388.5%) | - |
| Jun 2003 | - | $1.78M(+40.9%) |
| Mar 2003 | - | $1.27M |
| Dec 2002 | $4.22M | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of ALNY is $2.10B
What is the all time high annual operating expenses for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual total operating expenses is $2.10B
What is Alnylam Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, ALNY annual total operating expenses has changed by +$301.70M (+16.76%)
What is Alnylam Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of ALNY is $646.93M
What is the all time high quarterly operating expenses for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $646.93M
What is Alnylam Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, ALNY quarterly total operating expenses has changed by +$104.40M (+19.24%)